7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Han X et al. | Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. | 2009 | Oral Microbiol. Immunol. | pmid:19416447 |
Yildirim S et al. | Human cytomegalovirus, Epstein-Barr virus and bone resorption-inducing cytokines in periapical lesions of deciduous teeth. | 2006 | Oral Microbiol. Immunol. | pmid:16476020 |
Nakamura H et al. | Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo. | 2008 | Oral Microbiol. Immunol. | pmid:18402604 |
Lu HK et al. | An acute injection of Porphyromonas gingivalis lipopolysaccharide modulates the OPG/RANKL system and interleukin-6 in an ovariectomized mouse model. | 2008 | Oral Microbiol. Immunol. | pmid:18402608 |
Katagiri T and Takahashi N | Regulatory mechanisms of osteoblast and osteoclast differentiation. | 2002 | Oral Dis | pmid:12108759 |
Yamamoto T et al. | Mechanical stress induces expression of cytokines in human periodontal ligament cells. | 2006 | Oral Dis | pmid:16476039 |
Yamamoto K et al. | Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. | 2011 | Oral Dis | pmid:21771211 |
Park OJ et al. | The association of osteoprotegerin gene polymorphisms with periodontitis. | 2008 | Oral Dis | pmid:18938269 |
Nakano M et al. | Inhibitory effect of titanium particles on osteoclast formation generated by treatment of mouse bone marrow cells with PGE2. | 2003 | Oral Dis | pmid:12657033 |
Pitari MR et al. | Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. | 2015 | Oncotarget | pmid:26160841 |
Schieferdecker A et al. | Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. | 2014 | Oncotarget | pmid:25138051 |
Fioramonti M et al. | Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. | 2017 | Oncotarget | pmid:28223547 |
Murthy RK et al. | Bone biology and the role of the RANK ligand pathway. | 2009 | Oncology (Williston Park, N.Y.) | pmid:20128323 |
Shan Y et al. | p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells. | 2010 | Oncol. Rep. | pmid:20204301 |
D'Amico L et al. | Bone metastases in gastric cancer follow a RANKL-independent mechanism. | 2013 | Oncol. Rep. | pmid:23404437 |
Lv Z et al. | Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. | 2014 | Oncol. Rep. | pmid:24337584 |
Martinetti A et al. | Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response? | 2007 | Oncol. Rep. | pmid:17487415 |
Holecki M et al. | The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women. | 2007 | Obesity (Silver Spring) | pmid:17712108 |
Son E et al. | Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros. | 2007 | Nutrition | pmid:17664058 |
Pellegrini GG et al. | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. | 2016 | Nutrients | pmid:27409635 |
Martin-Bautista E et al. | Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. | 2010 | Nutr Res | pmid:20579524 |
Marini H et al. | Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. | 2010 | Nutr Metab Cardiovasc Dis | pmid:19631515 |
Huang JW et al. | Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. | 2014 | Nutr Metab Cardiovasc Dis | pmid:24361071 |
Mori T et al. | RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. | 2004 | Nucleic Acids Res. | pmid:15562003 |
Azuma Y | [Animal models of osteoporosis and development of anti-osteoporotic agents]. | 2007 | Nippon Yakurigaku Zasshi | pmid:17878615 |
Wada T | [RANKL inhibition in bone metastases]. | 2013 | Nippon Yakurigaku Zasshi | pmid:23302944 |
Kawaguchi H | [Approach for therapeutic targets of osteoarthritis]. | 2011 | Nippon Yakurigaku Zasshi | pmid:21747205 |
Inoue D and Matsumoto T | [Recent advances in basic research of bone metabolism]. | 2002 | Nippon Rinsho | pmid:11979916 |
Suzuki Y et al. | [Bone destruction and bone loss in rheumatoid arthritis--mechanism, prevention and treatment]. | 2002 | Nippon Rinsho | pmid:11979937 |
Suda T and Miyaura C | [Recent advance in basic research for osteoporosis]. | 2004 | Nippon Rinsho | pmid:15035090 |
Matsumoto T | [Recent advances in the regulation of bone remodeling]. | 2004 | Nippon Rinsho | pmid:15035093 |
Okumura S et al. | [Regulatory mechanism of osteoclast differentiation and function]. | 2004 | Nippon Rinsho | pmid:15035103 |
Udagawa N et al. | [Possible role of RANKL in bone resorption]. | 2004 | Nippon Rinsho | pmid:15035104 |
Okazaki T | [PTH-related protein producing tumor]. | 2006 | Nippon Rinsho | pmid:17022555 |
Inoue D | [OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)]. | 2004 | Nippon Rinsho | pmid:15035105 |
Suzuki Y | [Stimulator of bone resorption interleukin-1, interleukin-6 and gp-130 cytokine family]. | 2004 | Nippon Rinsho | pmid:15035106 |
Miyaura C | [LPS]. | 2004 | Nippon Rinsho | pmid:15035108 |
Tanaka Y | [Adhesion molecules in the context with bone remodeling and osteoporosis]. | 2004 | Nippon Rinsho | pmid:15035110 |
Tomoyasu A and Higashio K | [Osteoclastogenesis inhibitory factor/osteoprotegerin(OCIF/OPG)]. | 2004 | Nippon Rinsho | pmid:15035190 |
Sohen S | [Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases]. | 2004 | Nippon Rinsho | pmid:15035207 |
Tanaka Y | [Secondary osteoporosis due to systemic autoimmune diseases and rheumatic diseases]. | 2004 | Nippon Rinsho | pmid:15035208 |
Fukunaga J and Sugahara T | [Osteoporosis induced by immunosuppressant]. | 2004 | Nippon Rinsho | pmid:15035219 |
Juji T and Tanaka S | [Novel therapeutic approach to bone metabolic disorders using RANKL vaccination]. | 2004 | Nippon Rinsho | pmid:15035230 |
Chaki O | [Osteoporosis]. | 2006 | Nippon Rinsho | pmid:16689336 |
Takahashi N et al. | [Osteoprotegerin (OPG)]. | 2010 | Nippon Rinsho | pmid:20960766 |
Yasuda H | [OPG, anti-rANKL antibody]. | 2005 | Nippon Rinsho | pmid:16164225 |
Takahashi N et al. | [Osteoprotegerin (OPG)]. | 2005 | Nippon Rinsho | pmid:16149650 |
Takayanagi H | [Cross-talk between immune and skeletal systems]. | 2002 | Nippon Rinsho | pmid:12510352 |
Nakamura M et al. | [Osteoclastogenesis and bone resorption]. | 2009 | Nippon Rinsho | pmid:19432105 |
Masuda H and Tanaka S | [Drugs under development for osteoporosis ]. | 2009 | Nippon Rinsho | pmid:19432120 |